AGENDA

2022 Antibody Therapeutic Conference (ATC)

Extended Application of Antibody (draft)

Time: 2022.11.15 TUE

Venue: National Biotechnology Research Park, Nangang.

International Convention Hall (Building C)

Agenda:

Time Activities Speaker
9:00-9:30 Registration
9:30-9:40 Welcome Remarks

Chung-Hsiun Wu, Ph.D. 吳忠勳

Chairman, Taiwan Antibody Association President, Development Center for Biotechology

9:40-9:50 Moderator

Tse-Wen Chang, Ph.D. 張子文

President, Immunwork, Inc.

9:50-10:30 Bispecific Antibody: Sixty Years of Journey from Concept to Medicine

Herren Wu, Ph.D.  吳和仁

President, HW Biologics Consulting, LLC Former Senior Vice President, R&D, AstraZeneca

10:30-10:50 Break
10:50-11:30

Medicines from the central molecule of the ‘central dogma’: mRNA drugs and vaccines

Örn Almarsson, Ph.D.

Principal of AfiRx, LLC

Former CTO of Lyndra Therapeutics

11:30-12:00 Site-specific conjugation of cytotoxic drug bundles for homogeneous ADCs with high DAR of 6, 8, or 10

Hsing-Mao Art Chu, Ph.D 朱鑫懋

Vice President of R&D, Immunwork, Inc.

12:00-13:00 Lunch
13:00-13:10 3rd meeting of the 3rd TAA General Assembly

Chung-hsiun Wu, Ph.D. 吳忠勳

President, DCB/Chairman, TAA

Chih-Jung Chang, Ph.D. 張志榮

COO, EirGenix Inc./Secretary General, TAA

13:10-13:20 Moderator

Karen Wen, Ph.D. 溫國蘭

COO, GenomeFrontier Therapeutics Inc.

13:20-14:00 Adoptive T Cell Therapy of Cancer: First Principles for Lasting Responses

Cassian Yee, M.D. 余嘉誠

Professor, Department of Melanoma

Medical Oncology, Division of Cancer

Medicine, The University of Texas MD

Anderson Cancer Center

14:00-14:30

Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using qCART, the Quantum pBac-based CAR-T system

Sareina Chiung-Yuan Wu, Ph.D 吳瓊媛

CEO, GenomeFrontier Therapeutics Inc.

14:30-14:50 Break
14:50-15:00

Moderator

Han-Chung Wu, Ph.D 吳漢忠

Director, BioTReC

15:00-15:40

Development of Universal Vaccine

Chi-Huey Wong, Ph.D. 翁啟惠

Scripps Family Chair Professor, The

Scripps Research Institute

President Emeritus and Distinguished

Research Fellow, Academia Sinica

15:40-17:00

Panel Discussion:

Extended Application of Antibody

Moderator:

Han-Chung Wu, Ph.D 吳漢忠

Panelist:

Chung-Hsiun Wu, Ph.D. 吳忠勳

Tse-Wen Chang, Ph.D. 張子文

Karen Wen, Ph.D. 溫國蘭

Lee-Cheng Liu, Ph.D. 劉理成

Lih-jiuan Hsu, MD, Ph.D. 徐麗娟

James Chih-Hsin Yang, MD, Ph.D. 楊志新

Chiun Hsu, MD, Ph.D. 許 駿

Chia-Chi (Josh) Lin, MD, Ph.D. 林家齊

17:00-17:10

Closing Remarks

Election Results Announcement

Chung-Hsiun Wu, Ph.D. 吳忠勳

President, DCB/Chairman, TAA